Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1675 of 2406 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/31/07
End: 09/30/07
Due: 09/30/08
Phase: N/A
Priority: Normal
Start: 02/28/10
End: 01/31/11
Due: 01/31/12
Effect of HMG-CoA Reductase Inhibitors on the Meibomian Gland Morphology in Patients With Meibomitis
Phase: N/A
Priority: Normal
Start: 12/08/16
End: 01/31/20
Due: 01/31/21
Phase: N/A
Priority: Normal
Start: 08/31/99
End: 07/31/02
Due: 07/31/03
Phase: N/A
Priority: Normal
Start: 04/30/08
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 03/22/24
End: 02/04/25
Due: 02/04/26
Phase: N/A
Priority: Normal
Start: 01/31/00
End: 06/30/05
Due: 06/30/06
Phase: N/A
Priority: Normal
Start: 10/10/22
End: 10/09/30
Due: 10/09/31
Phase: N/A
Priority: Normal
Start: 07/23/24
End: 07/31/25
Due: 07/31/26
Phase: N/A
Priority: Normal
Start: 10/31/14
End: 08/31/15
Due: 08/31/16
Phase: N/A
Priority: Normal
Start: 07/06/20
End: 06/30/23
Due: 06/30/24
Phase: N/A
Priority: Normal
Start: 11/18/22
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 11/30/19
End: 09/30/21
Due: 09/30/22
Phase: N/A
Priority: Normal
Start: 10/31/13
End: 10/31/17
Due: 10/31/18
Phase: N/A
Priority: Normal
Start: 03/15/17
End: 12/31/17
Due: 12/31/18
Phase: N/A
Priority: Normal
Start: 02/01/18
End: 11/16/20
Due: 11/16/21
Phase: N/A
Priority: Normal
Start: 01/29/18
End: 12/31/19
Due: 12/31/20
Phase: N/A
Priority: Normal
Start: 08/01/14
End: 07/31/19
Due: 07/31/20
Phase: N/A
Priority: Normal
Start: 02/28/11
End: 02/28/13
Due: 02/28/14
Phase: N/A
Priority: Normal
Start: 08/31/14
End: 12/31/18
Due: 12/31/19
Phase: N/A
Priority: Normal
Start: 06/30/16
End: 05/10/19
Due: 05/10/20
Phase: N/A
Priority: Normal
Start: 09/01/21
End: 06/06/23
Due: 06/06/24
Phase: N/A
Priority: Normal
Start: 05/31/06
End: 12/31/16
Due: 12/31/17
Phase: N/A
Priority: Normal
Start: 02/09/21
End: 03/01/24
Due: 03/01/25
Phase: N/A
Priority: Normal
Start: 01/31/05
End: -
Due: -